# UTAH MED PRODS INC (UTMD)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/UTMD/

- Reporting holders: 4
- Reported value: $77.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $34.4K | 464 | 0.0% | 6 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $20.4K | 275 | 0.0% | 10 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $20.4K | 275 | 0.0% | 9 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.5K | 34 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $77.6K |
| Q2 2026 | 116 | $167.6M |
| Q1 2026 | 120 | $141.0M |
| Q4 2025 | 117 | $117.5M |
| Q3 2025 | 117 | $137.0M |
| Q2 2025 | 111 | $123.3M |
| Q1 2025 | 109 | $125.9M |
| Q4 2024 | 112 | $141.7M |
| Q3 2024 | 109 | $165.8M |
| Q2 2024 | 101 | $166.3M |
| Q1 2024 | 100 | $189.2M |
| Q4 2023 | 88 | $218.3M |